| 2025 | 2024 | |||
|---|---|---|---|---|
| Gross margin | 201,0 k € | +37.2% | 146,5 k € | |
| EBITDA | 200,4 k € | +37.0% | 146,3 k € | |
| Operating profit | 197,8 k € | +35.8% | 145,6 k € | |
| Profit/loss | 151,6 k € | +35.7% | 111,7 k € | |
| Equity | 265,6 k € | +131.2% | 114,8 k € | |
| Total assets | 317,7 k € | +104.2% | 155,6 k € | |
| Cash | 211,1 k € | +128.7% | 92,3 k € | |
| Debts | 52,2 k € | +28.1% | 40,7 k € | |
Source: Belgian Official Gazette
Private limited company · Woluwe-Saint-Lambert · incorporated on 31/01/2024
Private limited company profitable and well capitalised. Cash position rising (+128.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
AtomCare Nuclear Medicine is a Private limited company incorporated in 2024. Its registered office is in Woluwe-Saint-Lambert.